Results 171 to 180 of about 4,066,029 (306)

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Scientific production on instruments adapted to native languages in the Peruvian context. [PDF]

Front Psychol
Phoco-Arhuiri RM, Figueroa-Quiñones J, Cjuno J.   +2 more
europepmc   +1 more source

Bibliometric analysis of the worldwide scientific production on COVID-19 infection and cerebrovascular disease. [PDF]

Ann Card Anaesth, 2023
Palomino-Leyva C, Rivera-Recuenco J, Fernandez-Giusti A, Barja-Ore J, Retamozo-Siancas Y, Mayta-Tovalino F.   +5 more
europepmc   +1 more source

Institutional repositories and scientific production in Portuguese universities: current panorama

, 2021
Ramos, Cecília da Conceição Reis, Martins, Moisés de Lemos   +1 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Scientific Production on Chemical Burns: A Bibliometric Analysis (1946-2024). [PDF]

Eur Burn J
Cueva-Ramírez JE, Gonzalez-Alcaide G, Belinchón-Romero I, Ramos-Rincon JM.   +3 more
europepmc   +1 more source

SCIENTIFIC AND TECHNOLOGICAL ASPECTS OF CREATION AND PRODUCTION OF ROTARY PISTON ENGINES FOR UAVS ABROAD

, 2019
A. N. Kostyuchenkov, V.P. Minin, S.A. Klementyev, А. В. Федин   +3 more
openalex   +1 more source

Examination of Scientific Production on Badminton: A Content Analysis

, 2023
Mehmet Akarsu, Yahya Doğar
openalex   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

A bibliometric approach to worldwide scientific production of familial hypophosphataemic rickets in Scopus (2000-2022). [PDF]

Orphanet J Rare Dis
Hernández-García F, Gil-Peña H, López JM, Fuente R, Oro Carbajosa P, Corrales-Reyes IE, Suárez JR.   +6 more
europepmc   +1 more source